Press Releases
-
Quanticate announces plans to accelerate growth in North America
-
Calyx Advanced IRT Automation Saving Sponsors Time and Money
Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste
Nov 6, 2022
-
New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference
A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.
Nov 6, 2022
-
Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place
The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.
Nov 6, 2022
-
Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D
BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.
Nov 6, 2022
-
CD ComputaBio Introduces Four Docking Software for Drug Development
-
Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions
-
Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services
-
Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service
-
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
Nov 2, 2022
-
Jumo Health Honored in Inc.’s Inaugural Power Partner Awards
Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.
Nov 1, 2022
-
Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits
-
Creative Enzymes Expands Its Probiotic Portfolio
-
Rising Prevalence of Isotope Labeling Carbohydrates Drives Innovations at BOC Sciences
BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.
Nov 1, 2022
-
BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.
Nov 1, 2022
-
BOC Sciences Makes Easy Access to Polymerization Tech
Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.
Nov 1, 2022
-
BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.
Nov 1, 2022
-
Metatranscriptome Analysis Service Is Now Available at CD Genomics
-
Meet CD Genomics at the SITC 37th Annual Meeting
-
Expanded Offering of Fatty Amines for Diverse Applications